The bottom line now is, the crisis is ... we have a product that can save a lot of lives and how we're going to roll it out. And can we overcome all the defects at all, a few of the defects that he mentioned in the trial that I'm not sure at this point in time, whether they're real or not. So this...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
